A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Propranolol (HEMANGEOL)

INDICATIONS AND USAGE Hypertension Propranolol hydrochloride tablets are indicated in the management of hypertension.

First FDA approval1985-11-19
Generic availableYes · 15 mfrs
Shortage statusActive shortage
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$164.2M in CY2024 Part D spend6.4M claims · 1.9M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.051/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.051
Across all dosage forms in distribution.
Highest NADAC
$0.056
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Propranolol used for?

INDICATIONS AND USAGE Hypertension Propranolol hydrochloride tablets are indicated in the management of hypertension.

Is there a generic for Propranolol?

Yes. 58 ANDAs filed at FDA, 15 generic manufacturers currently shipping.

How much does my plan pay for Propranolol?

Across 329 Part D plans, Propranolol averages $0.051/unit (NADAC). Lowest available: $0.051/unit. Highest in distribution: $0.056/unit.

Is Propranolol on the FDA shortage list?

Yes. Propranolol is currently listed as an active FDA shortage.

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Beta-Adrenergic Blocker2 alternatives in D1
01
Bisoprolol
Brand: Bisoprolol
$0.157Lowest NADAC
11Generic mfrs
$44.2MCY24 Part D spend
Compare →
02
Metoprolol
Brand: KAPSPARGO
$0.017Lowest NADAC
31Generic mfrs
$853.0MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.